TGTX logo

TG Therapeutics (TGTX) Long Term Debt

Annual Long Term Debt

$109.35 M
+$27.87 M+34.21%

31 December 2023

TGTX Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Debt

$252.58 M
+$141.34 M+127.07%

30 September 2024

TGTX Quarterly Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TGTX Long Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+34.2%+132.9%
3 y3 years+503.2%+2420.7%
5 y5 years+100.0%+562.6%

TGTX Long Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+503.2%at high+2420.7%
5 y5 yearsat highat high+2420.7%
alltimeall timeat highat high

TG Therapeutics Long Term Debt History

DateAnnualQuarterly
Sept 2024
-
$252.58 M(+127.1%)
June 2024
-
$111.23 M(+0.9%)
Mar 2024
-
$110.29 M(+0.9%)
Dec 2023
$109.35 M(+34.2%)
$109.35 M(+0.8%)
Sept 2023
-
$108.43 M(+0.9%)
June 2023
-
$107.50 M(+0.9%)
Mar 2023
-
$106.58 M(+30.8%)
Dec 2022
$81.48 M(+6.3%)
$81.48 M(+1.1%)
Sept 2022
-
$80.62 M(+2.1%)
June 2022
-
$78.92 M(+1.7%)
Mar 2022
-
$77.57 M(+1.2%)
Dec 2021
$76.64 M(+322.7%)
$76.64 M(+664.8%)
Sept 2021
-
$10.02 M(-1.6%)
June 2021
-
$10.19 M(-1.6%)
Mar 2021
-
$10.35 M(-42.9%)
Dec 2020
$18.13 M(-53.7%)
$18.13 M(-27.1%)
Sept 2020
-
$24.88 M(-22.7%)
June 2020
-
$32.17 M(-18.3%)
Mar 2020
-
$39.36 M(+0.4%)
Dec 2019
$39.19 M(>+9900.0%)
$39.19 M(+2.8%)
Sept 2019
-
$38.12 M(+4.2%)
June 2019
-
$36.58 M(+0.3%)
Mar 2019
-
$36.47 M(>+9900.0%)
DateAnnualQuarterly
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
Mar 2014
-
$115.60 K(+79.2%)
Dec 2013
$64.50 K(-97.4%)
$64.50 K(-97.2%)
Sept 2013
-
$2.27 M(-4.1%)
June 2013
-
$2.36 M(-2.5%)
Mar 2013
-
$2.42 M(-2.2%)
Dec 2012
$2.48 M(-24.8%)
$2.48 M(-43.4%)
Sept 2012
-
$4.38 M(-0.3%)
June 2012
-
$4.40 M(-5.8%)
Mar 2012
-
$4.66 M(+41.6%)
Dec 2011
$3.29 M(-80.3%)
$3.29 M(-80.4%)
Sept 2011
-
$16.84 M(+0.7%)
June 2011
-
$16.73 M(+0.7%)
Mar 2011
-
$16.61 M(-0.9%)
Dec 2010
$16.76 M(+2404.1%)
$16.76 M(+0.9%)
Sept 2010
-
$16.61 M(+0.7%)
June 2010
-
$16.50 M(+0.3%)
Mar 2010
-
$16.45 M(+2357.7%)
Dec 2009
$669.20 K(-43.7%)
$669.20 K(-62.4%)
Sept 2009
-
$1.78 M(+4.7%)
June 2009
-
$1.70 M(+4.8%)
Mar 2009
-
$1.62 M(+36.4%)
Dec 2008
$1.19 M
$1.19 M(+266.6%)
June 2005
-
$324.40 K

FAQ

  • What is TG Therapeutics annual long term debt?
  • What is the all time high annual long term debt for TG Therapeutics?
  • What is TG Therapeutics annual long term debt year-on-year change?
  • What is TG Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for TG Therapeutics?
  • What is TG Therapeutics quarterly long term debt year-on-year change?

What is TG Therapeutics annual long term debt?

The current annual long term debt of TGTX is $109.35 M

What is the all time high annual long term debt for TG Therapeutics?

TG Therapeutics all-time high annual long term debt is $109.35 M

What is TG Therapeutics annual long term debt year-on-year change?

Over the past year, TGTX annual long term debt has changed by +$27.87 M (+34.21%)

What is TG Therapeutics quarterly long term debt?

The current quarterly long term debt of TGTX is $252.58 M

What is the all time high quarterly long term debt for TG Therapeutics?

TG Therapeutics all-time high quarterly long term debt is $252.58 M

What is TG Therapeutics quarterly long term debt year-on-year change?

Over the past year, TGTX quarterly long term debt has changed by +$144.15 M (+132.94%)